Our Products
- Upper Extremity
  - AMADEO® Finger-Hand-Rehabilitation
    
    With AMADEO® patients who are barely able or unable to grasp can perform hundreds of robot-assisted grasping movements. Active participation of the patient’s affected hand is promoted by biofeedback and assist-as-needed interactions.
  - DIEGO®Shoulder-Arm-Rehabiliation
    
    Whether proximal or distal training, DIEGO® purposefully supports the rehabilitation of natural motion, allows the handling of everyday objects to be relearned, and is usable by adults and children alike.
  - MYRO® Interactive and task-specific therapy
    
    MYRO®´s sensor-based surface enables task-oriented rehabilitation with real objects, trains the patient’s cognitive abilities, and improves motor abilities of the upper extremity.
  - PABLO® Upper Extremity Rehabilitation
    
    As a multifunctional rehabilitation device with comprehensive accessories, PABLO® enhances classical therapy exercises with biofeedback, objective assessments, and gamification.
  - TYROSTATION The perfect therapy setting
    
    The TYROSTATION is home to all components of PABLO® and TYMO® and provides ergonomic adaptability for patients.
- Lower Extremity
  - LEXO®Gait and Locomotion
    
    LEXO® is an end-effector-based gait trainer that revolutionizes gait rehabilitation through fast setup, high patient activity, and trunk support. Gait training with LEXO® means gait rehabilitation combined with scientific evidence.
  - OMEGO® Plus Gait training for the goals across all phases
    
    More than just a therapy bike! OMEGO® Plus combines uni- and bilateral leg training, leg press, stepper, cycling & foot lift training in one device.
  - TYMO® Balance training and postural control
    
    Small but powerful, the TYMO® system is a versatile measurement and therapy system for the whole body. In addition to the standing position, TYMO® offers a wide range of other options for maximum variety during therapy.
  - PABLO® Lower ExtremityPart of PABLO®
    
    PABLO® LOWER EXTREMITY is as an IMU-based gait analysis and training system part of PABLO®. It precisely assesses gait parameters that provide essential information for treatment of walking impairments.
- MTT-Line
  - MTT-LineMedical training therapy
    
    The barrier-free MTT-LINE specifically strengthens the six major muscle groups of the human body.
- Software
  - TyroS The heart of our technology
    
    Our TyroS software – developed by and together with therapists – is the heart of our technology that combines devices, know-how and therapeutic games. It is a sophisticated therapeutic system that helps challenge and encourage patients.

Tyromotion: Enhancement to the Management Level and 100 Employees

The management level at Tyromotion is getting reinforcements. Siegfried Schabel took up his position as CEO & CFO with the manufacturer of robotics and sensor-based rehabilitation technology in October 2022. Together with CTO Alexander Kollreider and CSO Wolfram Veitl, Tyromotion’s management team is now optimally positioned to continue the worldwide growth. On October 5, Siegfried Schabel introduced himself to the entire Tyromotion staff in a town hall meeting at the headquarters in Graz.

The management of Tyromotion: CSO Wolfram Veitl, CEO/CFO Siegfried Schabel and CTO Alexander Kollreider (from left to right).

From automotive, mechanical engineering and medical technology to the rehabilitation and therapy industry

Siegfried Schabel, a native of Salzburg, studied at the Vienna University of Economics and Business. He then moved out of Austria, first to London, where he worked as an auditor for Tenneco – a global conglomerate. Five years later, he moved to Edenkoben (Germany), where he worked for Tenneco Automotive as Financial Controller for another five years. Immediately afterwards, he spent a total of 18 years managing the fortunes of the MEC Group, headquartered in Bad Soden (Germany) – a leading global manufacturer of welding and cutting technology as well as medical equipment; 10 of those years as CFO, 8 more as CEO.

Outlook and strategic alignment

The signs at Tyromotion are set for growth and the innovative therapy and rehabilitation devices are in demand in more and more countries around the world. With his extensive know-how and experience, Siegfried Schabel will play a key role in driving forward the global strategy of the company – which recorded a 27 % increase in sales in 2021 and is again expected to achieve double-digit growth in 2022. The goal is to further expand the brand awareness of the Styrian company and its position as a global market leader in its industry. Siegfried Schabel is looking forward to his new tasks and challenges: “With the combination of this young, dynamic and motivated team and the high-quality products with which we can further improve people’s lives every day, great potential is opening up for Tyromotion worldwide.“

Tyromotion welcomes the 100th team member

In addition to Siegfried Schabel, three other new employees started their careers at Tyromotion at the beginning of October. This means that the workforce has now grown to exactly 100 people. Due to the pleasing company growth in recent years, Tyromotion is still looking for further talents for different areas of the company. “We position ourselves as an attractive employer in the region with diverse development opportunities. Creative and innovative minds are very welcome at our company,” states CSO Wolfram Veitl, about the opportunities for potential applicants.

About Tyromotion

Tyromotion was founded in 2007 and is a manufacturer of technology-based therapy and rehabilitation devices with the goal to sustainably improve people’s independence and quality of life. By using state-of-the-art technologies such as robotics, sensor technology, virtual reality and gamification, patients are accompanied through the rehabilitation process in a more intensive and motivating way. 100 employees at its own sites in Europe and North America and around 40 sales partners worldwide ensure a high level of proximity to customers. The strong focus on research and development with a reinvestment rate of 20 % in this area guarantees innovation at the highest level.